In March 2025, the company introduced new options to get a direct-to-purchaser offering of its Wegovy weight loss drug. The company set up a fresh pharmacy, named NovoCare, which might charge prospects $499 per month for entry to the drug, fewer than 50 percent the price of the drug as a result of other pharmaceutical distribution networks.[fifty t